Bringing science and development together through news and analysis

  • Study points to plethora of malaria drug targets

Shares

The malaria parasite
Plasmodium falciparum
Researchers have identified 466 proteins in the malaria parasite that could be fruitful targets for drugs against the disease, which kills millions of people each year, mostly in Africa.

The proteins, known as 'transit peptides', interact with special structures in the parasite's cells called plastids. Because human cells do not contain plastids, drugs that interfere with the action of these proteins can shut the parasites down without harming humans. Until now, however, transit peptides have been poorly understood and difficult to identify.

In this week's issue of Science, Bernardo Foth from the University of Melbourne, Australia, and colleagues report that they analysed hundreds of proteins from the malaria parasite and identified certain features unique to transit peptides. They then created artificial versions that lacked these characteristics and found — as expected — that the peptides could no longer work properly.

© SciDev.Net 2003

Link to paper in Science by Bernando Foth et al

Photo credit WHO/MAP/TDR
Republish
We encourage you to republish this article online and in print, it’s free under our creative commons attribution license, but please follow some simple guidelines:
  1. You have to credit our authors.
  2. You have to credit SciDev.Net — where possible include our logo with a link back to the original article.
  3. You can simply run the first few lines of the article and then add: “Read the full article on SciDev.Net” containing a link back to the original article.
  4. If you want to also take images published in this story you will need to confirm with the original source if you're licensed to use them.
  5. The easiest way to get the article on your site is to embed the code below.
For more information view our media page and republishing guidelines.